Patent US7004176B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US7004176B2 Expired / Lapsed US ⏱️ 0.0 years remaining

Heart valve leaflet locator

Assignee: Edwards Lifesciences AG
•
Filing: 2003-10-17
•
Granted: 2006-02-28
•
Expires: 2023-10-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Disclosed are methods and devices for determining valve leaflet orientation. A catheter is provided with a conformable, radiopaque target. The target is deployed within a valve, such as the mitral valve. The conformable target conforms to the coaptation axis in response to closing of the valve leaflets. That coaptation axis may then be visualized, and utilized to determine information about valve operation, or to assist in placement of devices in the vicinity of the valve.

Inventors

  • 👤 Jan Lau

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 14:08
CPC Classifications
A; A61; A61F; A61F2/00; A61F2/02; A61F2/24; A61F2/2442; A61F2/2451; A61B; A61B90/00; A61B90/39; A61F2/2472

Claims Analysis

Total Claims: 15
Claim 1
Independent Claim 66 words
A method of assessing the functionality of a heart valve, comprising the steps of: positioning a device within the valve, the device being conformable for conforming to the coaption axis of the valve and moveable in response to opening and closing of the valve; and observing the device when the valve is closed, to determine the spatial orientation of the coaptation axis for evaluating valve function.
Claim 2
Independent Claim 66 words
A method of assessing the functionality of a heart valve, comprising the steps of: positioning a device within the valve, the device being conformable for conforming to the coaption axis of the valve and moveable in response to opening and closing of the valve; and observing the device when the valve is closed, to determine the spatial orientation of the coaptation axis for evaluating valve function.
Claim 3
Dependent Claim 22 words
A method of assessing the functionality of a heart valve as in claim 1 , wherein the positioning step comprises transluminally positioning.
Claim 4
Dependent Claim 32 words
A method of assessing the functionality of a heart valve as in claim 2 , comprising the steps of transluminally advancing the device through the aortic valve and into the mitral valve.
Claim 5
Dependent Claim 36 words
A method of assessing the functionality of a heart valve as in claim 2 , comprising the steps of transluminally advancing the device into the right atrium and across the atrial septum into the mitral valve.
Claim 6
Dependent Claim 29 words
A method of assessing the functionality of a heart valve as in claim 1 , wherein the positioning step comprises positioning a plurality of radiopaque markers within the valve.
Claim 7
Independent Claim 84 words
A method of determining leaflet orientation of a mitral valve, comprising the steps of: advancing the distal end of a catheter through the left ventricle to a position adjacent the mitral valve; deploying a radiopaque target from the distal end of the catheter to a location within the mitral valve, the radiopaque target being sufficiently conformable to reconfigure in response to opening and closing of the mitral valve; and observing the alignment of the radiopaque target in response to closing of the mitral valve.
Claim 8
Independent Claim 84 words
A method of determining leaflet orientation of a mitral valve, comprising the steps of: advancing the distal end of a catheter through the left ventricle to a position adjacent the mitral valve; deploying a radiopaque target from the distal end of the catheter to a location within the mitral valve, the radiopaque target being sufficiently conformable to reconfigure in response to opening and closing of the mitral valve; and observing the alignment of the radiopaque target in response to closing of the mitral valve.
Claim 9
Dependent Claim 17 words
A method as in claim 6 , wherein the radiopaque target comprises a plurality of radiopaque markers.
Claim 10
Dependent Claim 27 words
A method as in claim 7 , further comprising a plurality of wires and wherein the plurality of radiopaque markers are disposed on the plurality of wires.
Claim 11
Dependent Claim 25 words
A method as in claim 7 , further comprising an expandable basket and wherein the plurality of radiopaque markers are disposed on the expandable basket.
Claim 12
Independent Claim 90 words
A method of assessing the functionality of a valve, comprising the steps of: providing a conformable target, the conformable target having a primary axis and configured to conform to the coaption axis of the valve during opening and closing of the valve; positioning the conformable target within the valve; visualizing the target along a viewing axis which is transverse to the primary axis, in the vicinity of the valve; and observing the orientation of the target when the valve is open and closed for assessing the functionality of the valve.
Claim 13
Independent Claim 90 words
A method of assessing the functionality of a valve, comprising the steps of: providing a conformable target, the conformable target having a primary axis and configured to conform to the coaption axis of the valve during opening and closing of the valve; positioning the conformable target within the valve; visualizing the target along a viewing axis which is transverse to the primary axis, in the vicinity of the valve; and observing the orientation of the target when the valve is open and closed for assessing the functionality of the valve.
Claim 14
Dependent Claim 30 words
A method of assessing the functionality of a heart valve as in claim 1 , comprising positioning an implant within the coronary sinus in a preselected relationship to the device.
Claim 15
Dependent Claim 33 words
A method of assessing the functionality of a heart valve as in claim 11 , wherein the implant is positioned such that it applies pressure on a posterior leaflet of the mitral valve.

References Cited (Backward Citations)

US5876419A Cited
US4164046A Cited
US4954126B1 Cited
US4655771A Cited
US4954126A Cited
US4655771B1 Cited
US5061275A Cited
US5104404A Cited
US5674280A Cited
US5064435A Cited
US5006106A Cited
US5170802A Cited
US5163955A Cited
US5383892A Cited
US5919233A Cited
US5476471A Cited
US5571135A Cited
US5607444A Cited
WO1995016407A1 Cited
US5584879A Cited
US5980552A Cited
EP0727239A2 Cited
US5534007A Cited
US5593442A Cited
WO1996040356A1 Cited
US5741274A Cited
US20020022880A1 Cited
US6221103B1 Cited
US20020111533A1 Cited
DE19605042A1 Cited
DE19611755A1 Cited
US6027525A Cited
US5713949A Cited
US5824071A Cited
WO1998018411A1 Cited
US5911732A Cited
US5817126A Cited
US6071292A Cited
US20020124857A1 Cited
US6203556B1 Cited
US6325826B1 Cited
US6409760B1 Cited
WO1999044534A1 Cited
WO1999053977A1 Cited
US6626915B2 Cited
US6224612B1 Cited
US6093203A Cited
US6250308B1 Cited
US6402680B2 Cited
US6264602B1 Cited
US20020019660A1 Cited
US6402679B1 Cited
US6183411B1 Cited
WO2000018320A1 Cited
US6350277B1 Cited
WO2000041649A1 Cited
WO2000044313A1 Cited
US6629534B1 Cited
US6264691B1 Cited
US6626899B2 Cited
US6669687B1 Cited
US20040133192A1 Cited
WO2001000111A1 Cited
US6210432B1 Cited
US20010018611A1 Cited
US20040039443A1 Cited
WO2001050985A1 Cited
US20020103533A1 Cited
US20040133220A1 Cited
WO2001054618A1 Cited
US6537314B2 Cited
US6709456B2 Cited
US6706065B2 Cited
US20020151961A1 Cited
US20010044568A1 Cited
US20020016628A1 Cited
US20040153146A1 Cited
US20040138744A1 Cited
US6402781B1 Cited
US6248119B1 Cited
US6569198B1 Cited
WO2001085061A2 Cited
WO2001089426A1 Cited
WO2002000099A2 Cited
WO2002005888A1 Cited
WO2002001999A2 Cited
US6343605B1 Cited
WO2002034118A2 Cited
US6458145B1 Cited
US20020087173A1 Cited
WO2002053206A2 Cited
WO2002060352A1 Cited
US6810882B2 Cited
US6656221B2 Cited
WO2002062408A2 Cited
WO2002062270A1 Cited
WO2002062263A2 Cited
US6790231B2 Cited
US20020183837A1 Cited
WO2002096275A2 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2009-02-27 2009-08-29 2010-02-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2013-02-27 2013-08-29 2014-02-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2017-02-27 2017-08-29 2018-02-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag